Gene · 57721
NIH grants1,078
NIH grants whose papers are about the gene, through NIH's grant-paper links.
421 to 440 of 1,078
Download this page as JSON| Grant | Title | METTL14 papers | Newest fiscal year |
|---|---|---|---|
| R01AG017917 | Epidemiologic Study of Neural Reserve and Neurobiology of Aging | 1 | 2023 |
| R01AG061798 | Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines | 1 | 2023 |
| R01AG062577 | Epigenetic roles of DNA adenine methylation in Alzheimer's Disease | 1 | 2023 |
| R01AG064786 | Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain | 1 | 2023 |
| R01AI111784 | Molecular mechanism of RIG-I and RIPLET in antiviral signaling | 1 | 2023 |
| R01AI141816 | Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses | 1 | 2023 |
| R01CA174793 | BET bromodomain inhibition as targeted therapy in acute myeloid leukemia | 1 | 2023 |
| R01CA193256 | Dietary methionine and cancer | 1 | 2023 |
| R01CA226281 | The Long Noncoding RNA MALAT1 in Liver Cancer | 1 | 2023 |
| R01CA226759 | Targeting NSD1 in leukemia | 1 | 2023 |
| R01CA227602 | Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer | 1 | 2023 |
| R01CA228406 | Targeting immune stroma interactions in pancreatic cancer | 1 | 2023 |
| R01CA230339 | Lipid nanoprobe integrated microdevice for extracellular vesicle isolation and duplex sequencing based mutation detection for non-invasive lung cancer diagnosis | 1 | 2023 |
| R01CA230514 | Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms | 1 | 2023 |
| R01CA234605 | The Role of p53-R249S’s GOF in HCC development | 1 | 2023 |
| R01CA236118 | Role of the METTL13 Lysine Methyltransferase in Signaling and Cancer | 1 | 2023 |
| R01CA244074 | Epigenetic Regulation of KSHV Genome Replication | 1 | 2023 |
| R01CA248355 | Investigating Amino Acid Depletion in the Tumor Microenvironment as a Metabolic Immune Checkpoint | 1 | 2023 |
| R01DE023641 | Signaling and Targeting of CRTC1-MAML2 Fusion Oncoprotein in Salivary Gland | 1 | 2023 |
| R01DK081705 | Transforming growth factor beta1, microRNAs, lncRNA and diabetic nephropathy | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/grants?page=22